Pharmaceutical Patent Settlements : Issues in Innovation and Competitiveness.

Format:

Book

Government document

Author/Creator:

Library of Congress. Congressional Research Service. Resources, Science, and Industry Division.

Language:

English

Subjects (All):

Actions and defenses.

Medical economics.

Patents.

Pharmaceutical industry.

Physical Description:

1 online resource (1 online resource (16 p), digital, PDF file)

monochrome

Place of Publication:

[Place of publication not identified] : [publisher not identified], 2013.

System Details:

text file

Summary:

Introduces and analyzes innovation and competition policy issues associated with pharmaceutical patent litigation settlements. Reviews pharmaceutical patent litigation procedures under the Hatch-Waxman Act, which revised patent laws as applied to pharmaceutical products to accelerate generic drug approval process. Explains concept of reverse payment settlements, analyzes status of reverse payment settlements under the antitrust laws, and summarizes Congressional issues and possible alternatives.

Notes:

Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed May 2014). Reuse except for individual research requires license from ProQuest, LLC.

CRS Report.

Other Format:

Microfiche version: Library of Congress. Congressional Research Service. Resources, Science, and Industry Division. Pharmaceutical Patent Settlements

Access Restriction:

Restricted for use by site license.